HACKENSACK, N.J. (AP) — HACKENSACK, N.J. (AP) — Protalix BioTherapeutics Inc. (PLX) on Wednesday reported a loss of $5.5 million in its fourth quarter.
On a per-share basis, the Hackensack, New Jersey-based company said it had a loss of 7 cents.
The drug developer posted revenue of $9.1 million in the period.
For the year, the company reported a loss of $6.6 million, or 8 cents per share. Revenue was reported as $52.7 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PLX at https://www.zacks.com/ap/PLX
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
